Sequential development of monoclonal B cell lymphocytosis-derived small lymphocytic lymphoma and plasma cell leukemia

Ann Hematol. 2018 May;97(5):917-919. doi: 10.1007/s00277-018-3248-2. Epub 2018 Feb 7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Anemia, Hemolytic, Autoimmune / complications
  • Anemia, Hemolytic, Autoimmune / drug therapy
  • Antigens, CD / analysis
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow / pathology*
  • Bortezomib / administration & dosage
  • Clonal Evolution*
  • Clone Cells / chemistry
  • Clone Cells / pathology
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Dexamethasone / administration & dosage
  • Dexamethasone / adverse effects
  • Disease Progression
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
  • Leukemia, Plasma Cell / pathology*
  • Lymphocytosis / complications
  • Lymphocytosis / pathology*
  • Melphalan / administration & dosage
  • Prednisolone / adverse effects
  • Prednisolone / therapeutic use
  • Rituximab / administration & dosage
  • Rituximab / adverse effects
  • Rituximab / therapeutic use

Substances

  • Antigens, CD
  • Immunosuppressive Agents
  • Rituximab
  • Bortezomib
  • Dexamethasone
  • Cyclophosphamide
  • Prednisolone
  • Melphalan